FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31 Conference Center, the Great Room (Rm. 1503)  

10903 New Hampshire Avenue, Silver Spring, Maryland  

 

 

May 24, 2016 

MEETING ROSTER 

 
 
DESIGNATED FEDERAL OFFICER (Non-Voting) 
 

LaToya Bonner, PharmD, NCPS 
Division of Advisory Committee and Consultant Management 
Office of Executive Programs, CDER, FDA 

 

 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting) 

Daniel Budnitz, MD, MPH 
Medical Officer, Division of Healthcare Quality 
Promotion 
Director, Medication Safety Program 
Centers for Disease Control and Prevention 
Atlanta, Georgia 
 
Brendan M. Everett, MD, MPH 
Assistant Professor of Medicine 
Harvard Medical School 
Director, General Cardiology Inpatient Service 
Brigham and Women’s Hospital 
Boston, Massachusetts 
 
James D. Neaton, PhD 
Professor of Biostatistics 
Division of Biostatistics 
School of Public Health 
University of Minnesota 
Minneapolis, Minnesota  

Charles A. Stanley, MD 
Professor of Pediatrics 
University of Pennsylvania  
Perelman School of Medicine 
Division of Endocrinology  
Children’s Hospital of Philadelphia 
Philadelphia, Pennsylvania  
 

David W. Cooke, MD 
Associate Professor of Pediatrics 
Interim  Director, Pediatric Endocrinology 
Johns Hopkins University School of Medicine 
Baltimore, Maryland 
 

Diana Hallare, MPH  
(Consumer Representative) 
Visalia, California 
 

Robert J. Smith, MD 
(Chairperson) 
Professor of Medicine (Endocrinology) 
The Warren Alpert School of Medicine 
Professor of Health Services, Policy and Practice 
Brown University 
Providence, Rhode Island 
 
Peter W. F. Wilson, MD 
Director 
Epidemiology and Genomic Medicine 
Atlanta Veterans Administration Medical Center 
Professor of Medicine and Public Health 
Emory University 
Emory Clinical Cardiovascular Research Institute 
Atlanta, Georgia 
 
 
 
 

Page 1 of 3 

 

 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

May 24, 2016 

 

MEETING ROSTER (cont.) 

 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting) 
(cont.) 
 

 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBER (Non-
Voting) 
 

 

 

Susan Z. Yanovski, MD 
Co-Director, Office of Obesity Research 
Senior Scientific Advisor for Clinical Obesity 
Research 
National Institute of Diabetes and Digestive and 
Kidney Diseases 
National Institutes of Health (NIH) 
Bethesda, Maryland 

Reshma Kewalramani, MD  
(Industry Representative) 
Vice President, US Medical Organization 
Amgen 
Thousand Oaks, California 

 

 
TEMPORARY MEMBERS (Voting)  
 

Barbara Berney 
(Patient Representative) 
Rockford, Illinois 

Kenneth Burman, MD 
Director, Section of Endocrinology 
MedStar Washington Hospital Center  
Director, Integrated Endocrine Training Program 
MedStar Georgetown University Hospital 
Washington, District of Columbia 
 
Timothy S. Lesar, PharmD 
Patient Care Service Director  
Director of Clinical Pharmacy Services 
Albany Medical Center 
Albany, New York 
 

Martha C. Nason, PhD 
Mathematical Statistician 
Division of Clinical Research 
National Institute of Allergy and Infectious 
Diseases, National Institutes of Health 
Bethesda, Maryland 
 
 

Marie C. Gelato, MD, PhD 
Professor of Medicine 
Director, Master’s Program in Clinical Research 
Stony Medicine 
Stony Brook University 
Stony Brook, New York 
 
Steven B. Meisel, PharmD 
System Director of Patient Safety 
Fairview Health Services 
Minneapolis, Minnesota 
 

 

Page 2 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

 

 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

 
 
TEMPORARY MEMBERS (Voting) (cont.) 
 

Michael D. Reed, PharmD, FCCP,  FCP 
Director 
Rainbow Clinical Research Center 
Rainbow Babies and Children’s Hospital 
University Hospitals Case Medical Center 
Cleveland, Ohio 

 
FDA PARTICIPANTS (Non-Voting) 
 
Mary Parks, MD 
Deputy Director 
Office of Drug Evaluation II (ODE-II) 
Office of New Drugs (OND), CDER, FDA 
 

Lisa Yanoff, MD 
Clinical Team Leader 
DMEP, ODE-II, OND, CDER, FDA 
 
Anna Kettermann, Dipl. Math, MA 
Biostatistician 
Division of Biostatistics (DB) II 
Office of Biostatistics (OB)  
Office of Translational Sciences (OTS) 
CDER, FDA 

 

 

May 24, 2016 

 

MEETING ROSTER (cont.) 

 
 

Jean-Marc Guettier, MDCM 
Director  
Division of Metabolism and Endocrinology Products 
(DMEP) 
ODE-II, OND, CDER, FDA 
 
Tania Condarco, MD 
Clinical Reviewer 
DMEP, ODE-II, OND, CDER, FDA 
 
 

Page 3 of 3 

